Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 31 04:00PM ET
28.66
Dollar change
+0.46
Percentage change
1.63
%
IndexS&P 500 P/E- EPS (ttm)-0.06 Insider Own0.04% Shs Outstand5.67B Perf Week-0.10%
Market Cap162.40B Forward P/E10.51 EPS next Y2.73 Insider Trans0.13% Shs Float5.66B Perf Month5.45%
Income-288.00M PEG- EPS next Q0.45 Inst Own68.62% Short Float1.24% Perf Quarter7.78%
Sales55.09B P/S2.95 EPS this Y27.63% Inst Trans0.52% Short Ratio1.69 Perf Half Y-4.72%
Book/sh16.28 P/B1.76 EPS next Y16.14% ROA-0.14% Short Interest70.22M Perf Year-24.62%
Cash/sh2.10 P/C13.62 EPS next 5Y-0.53% ROE-0.30% 52W Range25.20 - 40.37 Perf YTD-0.45%
Dividend Est.1.69 (5.90%) P/FCF31.81 EPS past 5Y-27.43% ROI-0.19% 52W High-29.00% Beta0.67
Dividend TTM1.66 (5.79%) Quick Ratio0.78 Sales past 5Y10.96% Gross Margin48.87% 52W Low13.73% ATR (14)0.60
Dividend Ex-DateMay 09, 2024 Current Ratio1.05 EPS Y/Y TTM-101.00% Oper. Margin3.23% RSI (14)56.36 Volatility1.85% 2.07%
Employees88000 Debt/Eq0.75 Sales Y/Y TTM-40.73% Profit Margin-0.52% Recom2.26 Target Price32.57
Option/ShortYes / Yes LT Debt/Eq0.66 EPS Q/Q-43.40% Payout439.41% Rel Volume1.81 Prev Close28.20
Sales Surprise7.25% EPS Surprise58.98% Sales Q/Q-18.61% EarningsMay 01 BMO Avg Volume41.64M Price28.66
SMA200.97% SMA504.98% SMA200-3.07% Trades Volume75,351,052 Change1.63%
Date Action Analyst Rating Change Price Target Change
Mar-22-24Downgrade Argus Buy → Hold
Feb-23-24Initiated Guggenheim Buy $36
Jan-04-24Downgrade TD Cowen Outperform → Market Perform $32
Oct-20-23Resumed UBS Neutral $36 → $34
Oct-16-23Upgrade Jefferies Hold → Buy $38 → $39
Jul-17-23Reiterated JP Morgan Neutral $45 → $41
Jul-14-23Initiated HSBC Securities Buy $50
Jun-29-23Downgrade Credit Suisse Outperform → Neutral $47 → $40
May-11-23Downgrade Daiwa Securities Outperform → Neutral $38
Mar-06-23Initiated Jefferies Hold $43
Today 03:00AM
May-31-24 05:01PM
12:20PM
12:18PM
12:07PM
11:53AM Loading…
11:53AM
11:31AM
10:56AM
10:23AM
08:04AM
08:00AM
07:07AM
05:47AM
03:30AM
May-30-24 04:03PM
11:44AM Loading…
11:44AM
09:22AM
06:40AM
05:45AM
04:45AM
May-29-24 04:23PM
10:07AM
09:31AM
06:30AM
06:00AM
May-28-24 10:11AM
09:00AM
06:22AM
May-27-24 06:58PM
06:55PM
06:47PM Loading…
06:47PM
06:43PM
06:34PM
06:28PM
06:28PM
06:13PM
12:59PM
May-26-24 05:39AM
May-25-24 11:10PM
09:00AM
May-24-24 01:46PM
08:45AM
08:00AM
05:00AM
May-23-24 02:31PM
02:01PM
11:10AM
09:30AM
May-22-24 06:43PM
05:28PM
05:22PM
05:17PM
04:38PM
01:44PM
12:52PM
11:44AM
09:48AM
09:31AM
06:30AM
May-21-24 03:04PM
02:48PM
10:58AM
09:30AM
06:27AM
05:21AM
03:11AM
May-20-24 04:54PM
04:18PM
03:29PM
02:31PM
02:09PM
10:52AM
07:16AM
05:47AM
04:37AM
04:22AM
May-19-24 08:08AM
06:51AM
May-17-24 02:46PM
01:17PM
12:36PM
09:00AM
07:11AM
May-16-24 10:51AM
09:45AM
08:48AM
08:07AM
07:15AM
07:01AM
06:15AM
06:00AM
05:42AM
12:35AM
12:11AM
12:08AM
May-15-24 08:19AM
06:00AM
05:21AM
May-14-24 02:23PM
10:07AM
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOURLA ALBERTChairman & CEOFeb 23 '24Option Exercise27.34127,6743,490,607439,748Feb 27 01:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23 '24Option Exercise27.3495,7552,617,942230,920Feb 27 01:46 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23 '24Option Exercise27.3463,8371,745,304218,148Feb 27 01:46 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23 '24Option Exercise27.3429,436804,780123,073Feb 27 01:46 PM
McDermott MichaelExecutive Vice PresidentFeb 23 '24Option Exercise27.3412,412339,34495,408Feb 27 01:47 PM
SAHNI PAYALExecutive Vice PresidentFeb 23 '24Option Exercise27.3411,527315,14834,604Feb 27 01:46 PM
BOSHOFF CHRISTOFFELExecutive Vice PresidentFeb 23 '24Option Exercise27.349,752266,620148,703Feb 27 01:44 PM
DAMICO JENNIFER B.SVP & ControllerFeb 23 '24Option Exercise27.349,752266,62019,228Feb 27 01:46 PM
Gottlieb ScottDirectorDec 15 '23Buy26.473,00079,4019,000Dec 19 09:31 AM